1. Home
  2. FPI vs PCRX Comparison

FPI vs PCRX Comparison

Compare FPI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPI
  • PCRX
  • Stock Information
  • Founded
  • FPI 2013
  • PCRX 2006
  • Country
  • FPI United States
  • PCRX United States
  • Employees
  • FPI N/A
  • PCRX N/A
  • Industry
  • FPI Real Estate Investment Trusts
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPI Real Estate
  • PCRX Health Care
  • Exchange
  • FPI Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • FPI 516.0M
  • PCRX 1.2B
  • IPO Year
  • FPI 2014
  • PCRX 2011
  • Fundamental
  • Price
  • FPI $11.08
  • PCRX $22.90
  • Analyst Decision
  • FPI
  • PCRX Buy
  • Analyst Count
  • FPI 0
  • PCRX 8
  • Target Price
  • FPI N/A
  • PCRX $28.38
  • AVG Volume (30 Days)
  • FPI 466.0K
  • PCRX 545.0K
  • Earning Date
  • FPI 07-23-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • FPI 2.17%
  • PCRX N/A
  • EPS Growth
  • FPI 104.48
  • PCRX N/A
  • EPS
  • FPI 1.09
  • PCRX N/A
  • Revenue
  • FPI $56,535,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • FPI N/A
  • PCRX $7.54
  • Revenue Next Year
  • FPI N/A
  • PCRX $10.78
  • P/E Ratio
  • FPI $10.19
  • PCRX N/A
  • Revenue Growth
  • FPI N/A
  • PCRX 3.08
  • 52 Week Low
  • FPI $9.66
  • PCRX $11.16
  • 52 Week High
  • FPI $12.87
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • FPI 42.06
  • PCRX 35.82
  • Support Level
  • FPI $11.43
  • PCRX $22.82
  • Resistance Level
  • FPI $11.69
  • PCRX $23.83
  • Average True Range (ATR)
  • FPI 0.17
  • PCRX 0.74
  • MACD
  • FPI -0.07
  • PCRX -0.02
  • Stochastic Oscillator
  • FPI 15.38
  • PCRX 6.22

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: